Search results
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 2 hours agoMerck slightly raised the upper end of its 2024 revenue guidance range from $62.7-$64.2 billion to...
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Zacks via Yahoo Finance· 1 day agoBiopharma sales rose 6.3% in the quarter to €8.94 billion. Pharma sales increased 6.4% to €7.76...
Sanofi (SNY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 day agoDupixent continues to increase penetration in all approved indications, and we saw performance diversified further across all geographies, plus, of...
Sanofi Sales, Profit Beat Expectations
The Wall Street Journal· 1 day agoSanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength...
Health Care Roundup: Market Talk
The Wall Street Journal· 6 hours agoThe hospital operator’s 1Q revenue beat the brokerage’s expectations thanks to higher patient volume and revenue intensity, the analysts say. 2241 GMT –...
Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy By Investing.com
Investing.com· 1 day agoSanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday...
Zacks via Yahoo Finance· 1 day agoSince 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year....
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Zacks via Yahoo Finance· 2 days agoToday's Research Daily features new research reports on 16 major stocks, including Danaher...
